Nerelimomab
Modify Date: 2024-04-02 19:43:55
Nerelimomab structure
|
Common Name | Nerelimomab | ||
|---|---|---|---|---|
| CAS Number | 162774-06-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of NerelimomabNerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis[1][2]. |
| Name | Nerelimomab [usan:inn] |
|---|
| Description | Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Nerelimomab (7.5 mg/kg，静脉输注) 在复发性菌血症的狒狒模型中保护动物免于死亡[1]。 Animal Model: Baboon model of recurrent bacteremia (Challenged with E.coli)[1] Dosage: 7.5 mg/kg Administration: i.v. infusion Result: Improved organ function and attenuated cytokine and plasminogen activator inhibitor release. |
| References |
| No Any Chemical & Physical Properties |